In this study, the protective effects of L-arginine treatment in vivo on vascular reactivity of streptozotocin (STZ)-induced 12-week-old diabetic rats were examined. Loss of weight, polydipsia, polyphagia, hyperglycemia, hypoinsulinemia, and elevated levels of plasma cholesterol and triglyceride were observed in diabetic rats. L-arginine treatment (1 mg/mL in drinking water) did not significantly affect these metabolic and biochemical abnormalities. Plasma malondialdehyde (MDA) levels in untreated diabetic rats were also significantly higher than untreated controls. However, L-arginine treatment prevented the increase in MDA level of plasma of diabetic rats. Contractile responses, but not sensitivity to noradrenaline (NA), were significantly increased in diabetic rats compared to controls. Treatment of diabetic rats with L-arginine completely prevented the increase in NA responses. Relaxation response to acetylcholine (ACh), but not to sodium nitroprusside (SNP), in diabetic aorta has been found to be significantly decreased as compared with controls. However, there were no significant differences in pD 2 values of acetylcholine in either of the groups. L-arginine treatment increased the ACh responses to the control level. All effects of L-arginine on vascular reactivity were found to be specific for diabetic rats and not controls. These results suggest that functional abnormalities occurred in aorta from diabetic rat might at least in part result from L-arginine deficiency, and the lipid peroxidation-lowering effect of L-arginine may account for its protective effect on vascular reactivity of diabetic rats.
Introduction
(STZ)-diabetic rats, has been obtained (Macleod, 1985; Harris and Macleod, 1988; Abebe et al., 1990) . On the Mortality from cardiovascular disease, including hyother hand, there is good evidence that endotheliumpertension, atherosclerosis, microangiopathy, and condependent relaxation is impaired in diabetic patients gestive heart failure, is almost three times higher in the (McVeigh et al., 1992; McNally et al., 1994) as well as diabetic population than in the general population STZ-diabetic rats (Oyama et al., 1986; Kamata et al., (Garcia et al., 1974; Jarrett, 1989) . Although the aetiol-1989). Oxidative stress is believed to be major factor in ogy of vascular disorders in diabetes is not completely the development of vascular complications associated understood, it has been suggested that alterations in the with diabetes mellitus (Baynes, 1992; Cohen 1993 ; Tesreactivity of blood vessels to neurotransmitters and cirfamariam, 1994; Giuglino et al., 1995) . Chang et al. culating hormones are responsible for the functional (1993) reported that increased maximal response to abnormalities of blood vessels in diabetes (Christlieb et vasoconstricting agents was due to a deficiency in al., 1976; Weidmann et al., 1985) . Although there are endothelium-dependent relaxation and increased NAconflicting results, in a great number of the previous induced phosphoinositide turnover in aortas from studies, increased vascular responsiveness to contractile diabetic rats, and that both the decreased endothelial agents, such as noradrenaline (NA) in streptozotocin activity and the augmented contractility resulted from increased oxidative stress in STZ-diabetic rats. Another possible mechanism involved in abnormal endothelium-plasma levels of arginine have been found to be reduced Bayer Diagnostics, Puteaux, France) and blood glucose test strips (Glucofilm, Bayer Diagnostics, Germany). in diabetic patients (Hagenfeldt et al., 1989; Grill et al., 1992) and in STZ-diabetic rats (Pieper and Peltier, Rats with blood glucose levels of 16.7 mM or above were considered to be diabetic. 1995; Pieper et al., 1996; Pieper and Dondlinger, 1997) . In addition, Pieper and Dondlinger (1997) have found 2.2. L-arginine treatment that vascular tissue arginine is also decreased in STZdiabetic rats. L-arginine incubation in organ bath reOne week after STZ injection, L-arginine-treated distores relaxation responses to ACh in aorta from STZ abetic and control rats were given drinking solutions (Pieper and Peltier, 1995; Pieper and Dondlinger, 1997) (distilled water) containing L-arginine at 1 mg/ml conor BB-diabetic rats, but it has no efcentration. Untreated control and diabetic rats received fect on control aorta. Pieper et al. (1996) has also shown distilled water alone. All rats were maintained for 12 that short-term (3 days) supplement of L-arginine in weeks with free access to food and water. Average food drinking water 8 weeks after induction of diabetes comand fluid intake were recorded twice per week. pletely reverses defective endothelium-dependent re-2.3. Isolation of aortic rings laxation and restores the decreased cGMP production stimulated by ACh in untreated diabetic rats to control Twelve weeks after the induction of diabetes, the levels. On the other hand, there are several reports rats were anesthetized with 60 mg/kg thiopental sodium showing that L-arginine can reduce lipid peroxidation (i.p.). After opening the abdomen, blood samples (3-5 (Xiong et al., 1994; Wascher et al., 1997; Lubec et al., ml) were taken from renal arteries, placed in heparin-1995, 1997a, 1997b) , which is associated with increased ized tubes, and centrifuged at 3.000 g for 20 min. The oxidative stress. Among these studies, it has been found plasma samples were stored in Ϫ30ЊC for determination that L-arginine reduces lipid peroxidation in diabetic of final glucose, insulin, triglyceride, and cholesterol patients (Lubec et al., 1997a) and diabetic kk mouse measurements. (Lubec et al., 1997b) . To our knowledge, however, Descending thoracic aortas were carefully excised there is no data concerning the effect of long-term and placed in cold physiological saline solution (PSS) L-arginine treatment on vascular reactivity and on lipid containing (mM): 118 NaCl, 4.7 KCl, 2.5 CaCl 2 , 1.2 peroxidation in STZ-diabetic rats. Therefore, in this MgSO 4 , 1.2 KH 2 PO 4 , 25 NaHCO 3 , and 11.1 glucose. The study, we evaluated the effects of chronic L-arginine aortas were cleaned of excess connective tissue and fat treatment on the vascular reactivity in diabetic aorta.
and cut into rings of approximately 3-5 mm in length. Furthermore, we also examined whether L-arginine
In all experiments, special care was taken to avoid damtreatment affects some metabolic and biochemical paaging the luminal surface of endothelium. Aortic rings rameters-including plasma levels of malondialdehyde were suspended in 20-ml jacketed organ baths filled (MDA), a marker of lipid peroxidation-in diabetic with 20 ml of PSS continuously aerated with a mixture and control rats. of 5% CO 2 , 95% O 2 , pH 7.4, at 37ЊC. One end of the aortic rings was connected to a tissue holder and the other to an isometric force transducer (No. 7004, Ugo
Materials and methods
Basile, Varese, Italy) connected to a microdynamometer (Unirecord, Ugo Basile). The rings were equilib-2.1. Animals rated for 60 min under a resting tension of 2 g before experiments were begun. During equilibration period, the Inbred male Wistar rats procured locally (body rings were washed every 15 min. All experiments were weight 170-220 g, 8-10 weeks old) were used in the done in the presence of 1 M timolol, 1 M imiprapresent study. The animals were housed in individual mine, and 1 M prednisolone to eliminate the effects of cages at a constant temperature (22ЊC) with a fixed ␤-adrenoceptors, neuronal uptake, and extraneuronal 12:12-h light-dark cycle (lights on 0700-1900). This uptake, respectively. study was approved by the Ethics Committee of the Faculty of Veterinary Medicine, University of Ankara.
2.4. Experimental procedure The animals were divided into four experimental groups: untreated control (n ϭ 9), L-arginine treated At the end of the equilibration period, a cumulative control (n ϭ 11), untreated diabetic (n ϭ 11), and concentration-response curve for NA (10
L-arginine-treated diabetic (n ϭ 11). Diabetes was inmol/L) was carried out. After rinsing with PSS to baseduced by a single tail vein injection of STZ (50 mg/kg).
line tension, rings were equilibrated for 30 min. The STZ was dissolved in 1 ml of cold citrate buffer (0.1 M, rings were then contracted with a submaximal concenpH 4.5) immediately before use. Control animals retration of NA, which produced 70-80% of maximal received the citrate buffer solution alone. Seven days sponse. The NA concentration was usually 1 mol/L after STZ injection, blood glucose levels were deterbut was varied between 3 ϫ 10 Ϫ7 -3 ϫ 10 Ϫ6 mol/L to obtain equieffective agonist activity. After reaching mined using an Ames glucometer (Glucometer III, the plateau of contraction, cumulative concentration-2.6. Drugs response curves to ACh (10 Ϫ8 -3 ϫ 10 Ϫ5 mol/L) and soStreptozotocin, (Ϫ) noradrenaline bitartrate, L-argidium nitroprusside (SNP; 10 Ϫ11 -10 Ϫ6 mol/L) were obnine hydrochloride, acetylcholine chloride, sodium tained to evaluate endothelium-dependent and -indenitroprusside, timolol maleate, imipramine hydrochlopendent relaxations, respectively. ride, BHT, and TBA were purchased from Sigma (St. After each experiment, aortic rings were dried at Louis, MO). Noradrenaline was dissolved in distilled 50ЊC for 5 min, weighed, and measured, and the crosswater containing 1 mg/ml ascorbic acid to prevent oxisectional area (csa) was calculated using the following dation of the drug. Thiopental sodium and prednisolon formula: Cross-sectional area (mm 2 ) ϭ weight (mg) ϫ were obtained from Abbott and Fako (Istanbul, Tur-[length (mm) ϫ density]
Ϫ1 . The density of the preparakey) respectively. tions was assumed to be 1.05 mg/mm 3 (Abebe et al., 1990) .
Data and statistical analysis
Results are expressed as the mean Ϯ SEM. Contrac-2.5. Biochemical measurements tile responses to NA are expressed in tension (g) in rePlasma insulin levels were measured by standard rasponse to the agonist per cross-sectional area of aorta dioimmunoassay techniques using a commercial kit (mm 2 ). Relaxation responses of ACh and SNP are exavailable from DPC (Diagnostic Products Corporation, pressed as a percentage decrease of the maximum conLos Angeles, CA). Final plasma glucose levels were detractile response. The sensitivity to the agonists is evalutermined by the glucose oxidation method using a gluated as the pD 2 , which is the negative logarithm of the cose kit (Glukofix, Menarini Diagnostics, Florence, Itconcentration of the drug required to produce 50% of aly). Menarini Diagnostics kits were also used to maximum response. EC 50 values were calculated using measure the levels of cholesterol and triglyceride in the non-linear regression analysis. Statistical analysis was plasma. The cholesterol and triglyceride levels were decarried out using one-way analysis of variance followed termined using enzymatic and colorimetric methods on by Neuman-Keul's test. Results were considered significantly different if p Ͻ 0.05. a programmable photometer (Fototron, Diatron, Wien, Austria). Plasma levels of MDA, one of the end products of lipid peroxidation, were determined by the thio-3. Results barbituric acid (TBA) reaction according to a slightly modified Satoh (1978) method. To 0.5 mL plasma, 2.5
At the end of 12 weeks, the body weight of the mL 20% trichloroacetic acid (TCA) and 0.025 mL buuntreated diabetic rats was found to be significantly detylated hydroxy-toluene (BHT; 88 mg/10 mL absolute creased compared with control rats (Table 1) . Unalcohol) were added, and then the tubes were left to treated diabetic rats also had elevated food and fluid instand for 10 min at room temperature. After centrifugatakes over those of control rats (Table 1) . Treatment of tion, the supernatant was decanted, and the precipitate diabetic rats with L-arginine did not cause any change was washed with sulfuric acid (0.05 mol/L) twice. Then in the above parameters of untreated diabetic rats (Tathe sulfuric acid and 0.2% TBA prepared in 2 mol/L soble 1). Similarly, L-arginine treatment did not signifidium sulphate were added to this precipitate and cantly alter food and fluid intake and weight gain of heated for 30 min in a boiling water bath. After cooling, control rats. In addition, no significant change was n-butanol was added, the tubes were vortexed and cenfound between the cross-sectional areas of all experitrifuged, and absorbance of the organic phase was read mental groups (Table 1) . Untreated and L-arginine-treated diabetic rats also at 530 nm. Table 1 Body weights, fluid intakes, food intakes, and cross-sectional areas (csa) of untreated control, L-arginine-treated control, untreated diabetic, and L-arginine-treated diabetic rats
Body weight
Fluid intake Food intake csa (g) (ml/day) (g/day) (mm ). In contrast, concentration-response curves and also maximum response (1.64 Ϯ 0.14 g/mm 2 ) of aortae (Table 2 ). Plasma MDA levels of untreated diabetic rats were significantly higher than untreated controls.
from L-arginine-treated diabetic rats to NA were very similar to those of aortae from untreated controls (Fig. While L-arginine treatment prevented significantly the increase in the lipid peroxidation in diabetic rats, it did 1). On the other hand, L-arginine treatment did not alter contractions to NA in control aortae. For example, not cause any difference in plasma MDA level of control rats (Table 2) . maximum response to NA was 1.75 Ϯ 0.25 g/mm 2 . With respect to pD 2 values of NA, there was no statistical 3.1. Contraction studies difference among the untreated control, L-arginine treated control, untreated diabetic, or L-arginineCumulative addition of NA (10 Ϫ8 -3 ϫ 10 Ϫ5 mol/L) to treated diabetic groups (Table 3) . the isolated organ bath resulted in concentrationdependent contractions in aortae of all groups (Fig. 1) .
Acetylcholine and SNP relaxation responses
The contractile responses to NA at the concentrations Addition of ACh resulted in concentration-depenhigher than 10 Ϫ7 M in the aortae from untreated diadent relaxations in all aorta rings precontracted with betic rats were found to be significantly increased com-NA. The ACh-induced relaxation was significantly repared to untreated control rats (Fig. 1) . Similarly, there duced in untreated diabetic rats relative to untreated was also a significant difference in the maximum concontrol rats. The maximum relaxation to ACh was 89.2 Ϯ 2.4 and 63.0 Ϯ 3.4% in untreated control and untreated diabetic aortae, respectively. While 12-week L-arginine treatment did not have any effect on AChinduced relaxation in control aortae, it prevented impairment in endothelium-dependent relaxation in diabetic rats (Fig. 2) . The maximum relaxations of aortae from L-arginine-treated control and L-arginine-treated diabetic rats were 87.6 Ϯ 2.9 and 82.3 Ϯ 3.7%, respectively. On the other hand, the sensitivity of the aortae from all experimental groups to ACh was similar (Table 3) . The relaxation response and the sensitivity to SNP, the endothelium-independent vasodilator, have been found not to be significantly different in the control, L-arginine-treated control, untreated diabetic, and L-arginine-treated diabetic rats (Fig. 3, Table 3 ). The results of the present study demonstrate that treated diabetic (n ϭ 11), and L-arginine-treated diabetic (n ϭ 11) aortic rings. * p Ͻ 0.05 significantly different from all other groups.
Discussion
aortae from 12-week STZ-diabetic rats are more re- sponsive to the contractile effects of NA than those treated control group. On the other hand, it is well from corresponding controls. Similar results showing known that endothelium-dependent relaxation response the increased vascular responsiveness to contractile to agonists such as ACh is impaired in diabetic rat aorta agents in STZ-diabetic rats have been obtained in most (Oyama et al., 1986; Kamata et al., 1989) . Similarly, we previous studies (Macleod, 1985; found that relaxation response to ACh was decreased in 1988; Abebe et al., 1990; Ö zçelikay et al., 1994) . The acuntreated diabetic rats. Therefore, in our study, it seems tual mechanism is not completely understood. Possible likely that enhanced contractile response to NA may be mechanisms that could have been involved in the inassociated with the defective endothelial activity. On creased vascular smooth muscle responsiveness to NA the other hand, the other possible mechanisms menin diabetic rats are deficient endothelial activity (Kationed above should not be ruled out. rasu and Altan, 1993; Chang et al., 1993), enhanced In this study, we hypothesized that L-arginine treatphosphoinositide (PI) metabolism (Abebe and Macment in vivo could prevent the abnormalities in vasculeod, 1991; Chang et al., 1993) , enhanced sensitivity of lar function brought about by diabetes and found that calcium channels (Abebe et al., 1990 (Abebe et al., , 1994 , and inlong-term treatment of diabetic rats with the precurcreased sensitivity to adrenergic agonists (Macleod and sor of endothelium-derived relaxing factor/nitric oxide McNeill, 1982) . However, our findings show that the in-(EDRF/NO) prevented impairment in vascular reactivcreased responsiveness of aortae from untreated diaity caused by experimental diabetes. Our results are betic rats to NA did not result from an alteration in consistent with those which show that L-arginine supthe sensitivity of tissue to this agonist because the pD 2 plementation in vitro (Pieper and Peltier, 1995 ; Pieper value was not significantly different from that of the unand Dondlinger, 1997; or in vivo (Pieper et al., 1996) normalizes endothelium-dependent Fig. 2 . Cumulative concentration-response curves of acetylcholine in untreated control (n ϭ 9), L-arginine-treated control (n ϭ 11), un- Fig. 3 . Cumulative concentration-response curves of sodium nitroprusside in untreated control (n ϭ 9), L-arginine-treated control (n ϭ treated diabetic (n ϭ 11), and L-arginine-treated diabetic (n ϭ 11) aortic rings precontracted with noradrenaline. * p Ͻ 0.05 significantly 11), untreated diabetic (n ϭ 11), and L-arginine-treated diabetic (n ϭ 11) aortic rings precontracted with noradrenaline. different from all other groups. relaxation in diabetic rat aorta. In addition, L-arginine stress is increased due to excessive production of oxygen-free radicals and decreased antioxidant defense also restores both the decrease in endothelium-dependent relaxation and the increase in vasoconstrictor resystems (Baynes, 1992; Oberlet, 1988) . The oxidative stress may cause development of long-term diabetic sponses in hypercholesterolemic rabbits (Rossitch et al., 1991; Phivthong-ngam et al., 1998) and in DOCA-salt complications as a result of glycoxidation and lipid peroxidation (Baynes, 1992, Kennedy and Lyons, 1997) . It hypertensive rats (Laurant et al., 1995) .
In the present study, the beneficial effect of chronic has been reported that oxidative stress increases DAG-PKC activity in hyperglycemic rat aorta (Kunisaki et al., L-arginine treatment on contraction and endotheliumdependent relaxation responses was specific for dia-1994) and results in impaired endothelium-dependent relaxation, increased PI turnover in response to NA, betic aortae because L-arginine treatment did not show any effect in control preparations. Our results also indiand enhanced contractile responses to NA and KCl via alterations in calcium channel activities in STZ-diabetic cate that L-arginine treatment did not increase the sensitivity of vascular smooth muscle of diabetic rats to NO rat aorta (Chang et al., 1993) . Therefore, the oxidative stress in diabetic animals might be responsible for augbecause relaxation response to SNP was not significantly affected by L-arginine treatment in vivo. These mented contractility together with deficient endothelial activity (Chang et al., 1993; Tesfamariam, 1994) . On the findings are consistent with previous results (Pieper and Peltier, 1995; Pieper and Dondlinger, 1997; other hand, in several studies, L-arginine in vitro has been shown to improve impairment in endothelium-1997). Although we did not test stereospecificity of the effect of L-arginine, it has been reported that exogedependent relaxation evoked by ACh and to reduce increased lipid peroxidation caused by oxygen-free radnous L-arginine but not D-arginine restores vascular reactivity in diabetic rats (Pieper and Peltier, 1995; Pieicals (Xiong et al., 1994; Wascher et al., 1997) In addition, it has been reported that stimulated superoxide per et al., 1997) or in hypercholesterolemic humans (Creager et al., 1992) and rabbits (Rossitch et al., 1991) .
anion production is significantly decreased in hypercholesterolemic rabbits treated with L-arginine in vivo In the present study, chronic L-arginine treatment did not cause a significant change in plasma insulin, glu- (Bö ger et al., 1995 (Bö ger et al., , 1997 . Therefore, a possible mechanism by which L-arginine supplementation improves cose, cholesterol, or triglyceride levels of diabetic rats. These findings show that long-term oral supplementathe vascular reactivity in diabetes may depend on inhibiting the oxidative stress. Indeed, in our study, there is tion of L-arginine normalizes the impairment in responsiveness of aorta from diabetic rats without improving a positive correlation between improved vascular reactivity and normalized lipid peroxidation in L-argimetabolic abnormalities. Similarly, L-arginine treatment in vivo did not affect cholesterol or glucose level nine-treated diabetic rats. Consistent with present findings, studies published recently showed that treatment in hypercholesterolemic rabbits (Bö ger et al., 1995 (Bö ger et al., , 1997 or diabetic rats (Pieper et al., 1996) , respectively. orally with L-arginine reduced the lipid peroxidation products in patients with diabetes (Lubec et al., 1997a) Several other mechanisms could contribute to the preventive effect of L-arginine on the functional abnorand in the diabetic mice (Lubec et al., , 1997b . However, whether the lipid peroxidation-lowering efmalities observed in the diabetic rat aorta. It has been reported that arginine concentrations are decreased in fect of L-arginine results from its direct superoxide scavenging properties or increasing NO synthesis indiplasma of diabetic patients (Hagenfeldt et al., 1989; Grill et al., 1992) and in plasma and vascular tissue of rectly is controversial because NO also has antioxidant activity per se in diabetic arteries (Pieper et al., 1992 ; STZ-diabetic rats (Pieper and Peltier, 1995; Pieper et al., 1996; Pieper and Dondlinger, 1997) . Although we Chang et al., 1993) On the other hand, advanced stage glycosylation end products (AGEs) such as N e -Carboxyhave not measured the levels of plasma or tissue arginine, lack of the amino acid levels, as shown in diabetic methyllysine (CML), which may be either a glycoxidation or lipoxidation product (Kennedy and Lyons, rats, may cause a decrease in EDRF/NO synthesis and consequently may attenuate endothelium-dependent 1997), accumulate in diabetes (Schnider and Kohn, 1980; Monnier et al., 1984) and can inactivate NO (Burelaxation. Therefore, in our study, it seems likely that L-arginine treatment may normalize endotheliumcala et al., 1991) . Because the concentration of CML in glomerular basement membrane collagen has been dependent relaxation by increasing arginine levels in plasma and vascular tissue. Our results in the present found to be reduced in the diabetic mice (Weninger et al., 1992; Lubec et al., , 1997b treated with study and previous findings (Pieper and Peltier, 1995; Pieper et al., 1996; Pieper and Dondlinger, 1997; L-arginine in vivo, and L-arginine can directly inhibit AGEs production in vitro (Servetnick et al., 1996) , it is et al., 1997) confirm the beneficial effect of L-arginine treatment in vitro or in vivo on decreased endotheliumpossible that L-arginine improves endothelium-dependent relaxation by preventing NO quenching induced dependent relaxation in response to ACh in aorta from diabetic rats.
by AGEs. Taken together, these findings suggest that the beneficial effect of L-arginine treatment in diabetic In the diabetic state, it is well known that oxidative Garcia, M.J., McNamara, P.M., Gordon, T., Kannell, W.B., 1974. rats is attributable to inhibition of the oxidative stress Morbidity and mortality in diabetics in the Framingham populacaused by the oxygen-free radicals.
tion sixteen-year follow-up study. Diabetes 23, [104] [105] [106] [107] [108] [109] [110] [111] In conclusion, the findings obtained in this study Giuglino, D., Ceriello, A., Paolisso, G., 1995. Diabetes mellitus, hy- show that chronic treatment of diabetic rats with pertension, and cardiovascular disease: Which role for oxidative L-arginine in vivo prevents the changes in the vascular stress? Metabolism 44, 363-368. Grill, V., Bjorkman, O., Gutniak, M., Lindqvist, M., 1992. Brain upreactivity observed in untreated diabetic rats and that take and release of amino acids in nondiabetic and insulin-depenthe beneficial effect of L-arginine on vascular reactivity dent diabetic subjects: important role of glutamine release for niof diabetic rats may result from its lipid peroxidationtrogen balance. Metabolism 41, [28] [29] [30] [31] [32] lowering effect. Therefore, it is suggested that L-argiHagenfeldt, L., Dahlquist, G., Persson, B., 1989. Plasma amino acids nine treatment in addition to hypoglycemic agents, e.g., in relation to metabolic control in insulin-dependent diabetic children. Acta Pediatr Scand 794, [278] [279] [280] [281] [282] insulin and oral antidiabetics, may be applied as a theraHarris, K.H., Macleod, K.M., 1988. Influence of the endothelium on peutic regimen for diabetic patients.
contractile responses of arteries from diabetic rats. Eur J Pharmacol 153, 55-64. Jarrett, R.J., 1989. Cardiovascular disease and hypertension in diabe-
